The effect of salbutamol on skeletal muscle in chronic heart failure

International Journal of Cardiology

Volumn 73, Issue 3, 2000, Pages 257-265

  Harrington, Derek ^a   Chua, T P ^a   Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chronic heart failure; Exercise; Salbutamol; Skeletal muscle

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; SALBUTAMOL;

ADULT; ARTICLE; BREATHING MUSCLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; EXERCISE; HEART FAILURE; HUMAN; LUNG FUNCTION; MUSCLE STRENGTH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKELETAL MUSCLE;

ALBUTEROL; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY MUSCLES;

EID: 0034738160     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00233-3     Document Type: Article

References (32)

1. Gibbs J.S.R., Keegan J., Wright C., Fox K.M., Poole-Wilson P.A. Pulmonary artery changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol. 15:1990;52-61.
2. Wilson J.R., Martin J.L., Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: Role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol. 53:1984;1308-1315.
3. Savin W.M., Haskell W.L., Schroeder J.S., Stinson E.B. Cardiopulmonary responses of cardiac transplant to graded symptom limited exercise. Circulation. 62:1980;55-60.
4. Clark A.L., Poole-Wilson P.A., Coats A.J.S. Exercise limitation in chronic heart failure: The central role of the periphery. J Am Col Cardiol. 28:1996;1092-1102.
5. Minotti J.R., Pillay P., Oka R., Wells L., Christoph I., Massie B.M. Skeletal muscle size: Relationship to muscle function in heart failure. J Appl Physiol. 75:1993;373-381.
6. Mancini D.M., Henson D., LaManca J., Levine S. Evidence of reduced respiratory muscle endurance in patients with heart failure. J Am Coll Cardiol. 24:1994;972-981.
7. Lipkin D., Jones D., Round J., Poole-Wilson P. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol. 18:1988;187-195.
8. McParland C., Krishnan B., Wang Y., Gallagher C.G. Inspiratory muscle weakness and dyspnoea in chronic heart failure. Am Rev Respir Dis. 146:1992;467-472.
9. Chua T.P., Anker S.D., Harrington D., Coats A.J.S. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. Br Heart J. 74:1995;381-385.
10. Opasich C., Ambrosino N., Felicetti G., et al. Heart failure related myopathy. Clinical and pathophysiological insights. Eur Heart J. 20:1999;1191-1200.
11. Coats A.J.S., Adamopoulos S., Radaelli A., et al. Controlled trial of physical training in chronic heart failure: Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation. 85:1992;2119-2131.
12. Magnusson G., Gordon A., Kaijser L., et al. High intensity knee extensor training, in patients with chronic heart failure. Major skeletal muscle improvement. Eur Heart J. 17:1996;1048-1055.
13. Mancini D.M., Henson D., LaManca J., Donchez L., Levine S. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure. Circulation. 91:1995;320-329.
14. Hambrecht R., Niebauer J., Fiehn E., et al. Physical training in patients with stable chronic heart failure: Effects on cardiopulmonary fitness and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol. 25:1995;1239-1249.
15. Emery P.W., Rothwell N.J., Stock M.J., Winter P.D. Chronic effects of β2 adrenergic agonists on body composition and protein synthesis in the rat. Biosci. Rep. 4:1984;83-91.
16. Choo J.J., Horan M.A., Little R.A., Rothwell N.J. Muscle wasting associated with endotoxaemia in the rat: Modification by the β2 adrenoreceptor agonist clembuterol. Biosci. Rep. 9:1989;615-621.
17. Choo J.J., Horan M.A., Little R.A., Rothwell N.J. Effects of the β2 adrenoreceptor agonist clembuterol, on muscle atrophy due to food deprivation in the rat. Metab Clin Exp. 39:1990;647-650.
18. Zeman R.J., Ludeman R., Easton T.G., Etlinger J.D. Slow to fast alterations in skeletal muscle fibres caused by clembuterol, a β2 receptor agonist. Am J Physiol. 254:1988;E726-E732.
19. Carter W.J., Lynch M.E. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. Metabolism. 43:1994;119-1125.
20. Martineau L., Horan M., Rothwell N.J., Little R.A. Salbutamol a β2-adrenoreceptor agonist, increases skeletal muscle strength in young men. Clin Sci. 83:1992;615-621.
21. Davies N., Denison D.M. Measurement of metabolic gas exchange and minute volume by mass spectrometry alone. Respiratory Physiology. 36:1979;261-267.
22. Francis G.S., Goldsmith S.R., Levine T.B., Olivari M.T., Cohn J.N. The neurohormonal axis in congestive heart failure. Ann Intern Med. 101:1984;370-377.
23. Saul J.P., Arai Y., Berger R.D., Lilly L.S., Colucci W.S., Cohen R.J. Assessment of autonomic regulations in chronic congestive heart failure by spectral analysis. Am J Cardiol. 61:1988;1292-1299.
24. Bristow M.R., Ginsburg R., Minobe W., et al. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Eng J Med. 307:1982;205-211.
25. Rothwell N.J., Stock M.J., Sudera D.K. Changes in tissue blood flow and β-receptor density of skeletal muscle in rats treated with the β2 adrenoreceptor agonist clembuterol. Br J Pharmacol. 90:1987;601-607.
26. Bristow M.R. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 22:(Suppl. A):1993;61A-71A.
27. Yang Y.T., McElligot M.A. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J. 261:1989;1-10.
28. Tikunov B., Levine S., Mancini D. Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation. 92:(Suppl.):1995;I541.
29. Bourdillon P.D.V., Dawson J.R., Foale R.A., Timmis A.D., Poole-Wilson P.A., Sutton G.C. Salbutamol in treatment of heart failure. Br Heart J. 43:1980;206-210.
30. Mettauer B., Jean-Lucein R., Burgess J.H. Detrimental arrhymogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure. Am Heart J. 109:1985;840-847.
31. Muscling in on clenbuterol. Lancet 1992;340:403.
32. Maltin C.A., Delday M.I., Watson J.S., Hyas S.D., Nevison I.M., Ritchie I.K., Gibson P.H. Clenbuterol, a beta-adrenoreceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci. 84:1993;651-654.